Today's News | Note: News feeds may no longer be available for the articles on this page.

Valeant closes on Dow Pharmaceutical Sciences 12:28 PM 1/2/2009
Bizjournals.com - Charlotte,NC,USA
Valeant Pharmaceuticals International has closed on its purchase of Dow Pharmaceutical Sciences Inc. The $285 million deal was announced on Dec 10, 2008. ...

Celgene warns that anticlot drug linked to deaths 7:06 AM 1/1/2009
The Associated Press
Celgene Corp sent a letter to doctors warning that a study of its drug Innohep to treat dangerous blood clots suggests it may increase the risk of death in elderly patients. ...

Esophageal cancer linked to osteoporosis drugs 6:05 AM 1/1/2009
Reuters - USA
Merck's popular osteoporosis drug Fosamax (alendronate) and other similar drugs may carry a risk for esophageal cancer. Since the initial marketing in 1995, the FDA has received 23 reports where patients developed esophageal tumors. ...

Labopharm Gets FDA Okay For Once-Daily Tramadol - Finally 12:02 PM 12/31/2008
CNNMoney.com - USA
The US FDA approved Labopharm Inc's Ryzolt, a once-daily formulation of painkiller tramadol. ...

FDA Drug Approvals Highest In Three Years 12:01 PM 12/31/2008
CNNMoney.com - USA
There were 24 first-of-a-kind drugs including the antidepressant Pristiq from Wyeth, Cephalon Inc's Treanda for certain types of leukemia and lymphoma, and Amgen Inc's Nplate and GlaxoSmithKline's Promacta to treat low platelet counts. ...

US FDA advisers to review Lilly, Daiichi clot drug 8:15 AM 12/31/2008
Reuters - USA
The FDA's cardiovascular and renal drugs committee will review Eli Lilly and Daiichi Sankyo's blood-clot preventer prasugrel on Feb 3. ...

No More Goodies for Doctors From Drug Makers 8:05 AM 12/31/2008
New York Times - United States
Pharmaceutical companies have voluntarily ended branded goodies like Viagra pens, Zoloft soap dispensers, and Lipitor mugs. ...

King Pharma completes $1.6 billion Alpharma buyout 7:39 AM 12/31/2008
BusinessWeek - USA
Alpharma is now a wholly owned subsidiary of King Pharmaceuticals Inc and its shares will no longer be publicly traded. ...

GlaxoSmithKline extends Genelabs tender offer 7:37 AM 12/31/2008
Forbes - NY,USA
GlaxoSmithKline lowered the deal's 90 percent requirement and extended the tender offer for shares of biotechnology company Genelabs Technologies Inc. ...

Northfield's red blood cell drug granted fast review 9:05 AM 12/30/2008
Reuters - USA
Northfield Laboratories Inc received a priority review for the company's human hemoglobin-based red cell substitute PolyHeme. ...

Biovail recalls certain lots of pain drug Ultram 8:55 AM 12/30/2008
Forbes - NY,USA
Biovail Corp is recalling certain lots of its chronic pain drug Ultram ER because of problems with tablets dissolving. ...

Actavis will buy Kadian from King, FTC says 6:00 AM 12/30/2008
Forbes - NY,USA
King Pharmaceuticals Inc will have to sell Alpharma's painkiller Kadian to the drug's maker Actavis Group to make sure there is still enough competition among sellers of oral long-acting opioid pain drugs. ...

Abbott Laboratories sued by Bayer for royalties from Humira ... 5:30 AM 12/30/2008
Chicago Tribune - United States
Bayer AG's HealthCare unit is demanding royalties on its top-selling product arthritis drug Humira from Abbott Laboratories. ...

German Government Plans New Pay System for Drug Wholesalers 5:20 AM 12/30/2008
Bloomberg - USA
A proposal which would take effect in 2010 has wholesalers getting a fixed fee plus a percentage-based logistics surcharge. ...

Savient says FDA gives fast review to gout drug 4:01 PM 12/29/2008
Forbes - NY,USA
The US FDA will give Savient Pharmaceuticals Inc's drug candidate pegloticase a priority six-month review. ...

<- Day Earlier | Today's News